1.The 2014 Hepatology Society of the Philippines consensus statements on the management of chronic hepatitis B.
Jamias Jade D. ; Balce-Santos Dulcinea A. ; Bocobo Joseph C. ; Labio Madalinee Eternity D. ; Lontok Ma. Antoinette DC. ; Macatula Therese C. ; Ong Janus P. ; Ong-Go Arlinking K. ; Wong Stephen ; Yu Ira I. ; Payawal Diana A.
Philippine Journal of Internal Medicine 2015;53(1):17-33
Chorinic hepatitis B virus (CHB) infection is a serious problem that affects over 300 million people worldwide and is highly prevalent in the Asia Pacific region. In the Philippines an estimate 7.3 million Filipinos or 16.7% of adults are chronically infected with HBV, more than twice the average prevalence in the Western Pacific region.
In view of the above, the Hepatology Society of the Philippines (HSP) embarked on the development of consensus statements on the management of hepatitis B with the primary objectives of standardizing approach to management, empowering other physicians involved in the management of hepatitis B and advancing treatment subsidy by the Philippine Health Insurance Corporation (PhilHealth).
The local guidelines include screening and vaccination general management, indications for assessment of fibrosis in those who did not meet treatment criteria. indications for treatment, on-treatment and post-treatment monitoring and duration of antiviral treatment. Recommendations on the management of antiviral drug resistance, management of special populations including patients with concurrent HIV or hepatitis C infection, women of child-bearing age (pregnancy and breastfeeding), patients with decompensated liver disease, patients receiving immunosuppressive medications or chemotherapy and patients in the setting of hepatocellular carcinoma are also included. However, the guidelines did not include management for patients with liver and other solid organ transplantation, patients on renal replacement therapy, and children.
The consensus statements will be amended accordingly as new therapies become available.
Hepatitis B ; Consensus ; Hepatitis B, Chronic ; Hepatitis B Virus ; Fibrosis ; Drug Therapy ; Carcinoma, Hepatocellular ; Liver Cirrhosis ; Hepatitis Delta Virus ; Hiv
Result Analysis
Print
Save
E-mail